Related Experiment Video
Updated: Jul 20, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Discovery of orally active butyrolactam 11beta-HSD1 inhibitors
Vince S C Yeh1, Ravi Kurukulasuriya, Steven Fung
1Metabolic Disease Research, Abbott Laboratories, 100 Abbott Park Road, AP-10-304B, Abbott Park, IL 60064, USA. vince.yeh@abbott.com
Abstract:
A series of metabolically stable butyrolactam 11beta-HSD1 inhibitors have been synthesized and biologically evaluated. These compounds exhibit excellent HSD1 potency and HSD2 selectivity, pharmacokinetic, and pharmacodynamic profiles.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Production of Pharmaceuticals
Inhibitors of Bacterial Protein Synthesis
Production of Antibiotics
Enzyme Inhibition
Inhibitors of Bacterial DNA Synthesis
